| scholarly article | Q13442814 |
| P356 | DOI | 10.1126/SCIENCE.3498987 |
| P698 | PubMed publication ID | 3498987 |
| P2093 | author name string | Greenfield L | |
| Youle RJ | |||
| Johnson VG | |||
| P433 | issue | 4826 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 536-539 | |
| P577 | publication date | 1987-10-01 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity | |
| P478 | volume | 238 |
| Q50962872 | Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins. |
| Q37329927 | An update in the use of antibodies to treat glioblastoma multiforme |
| Q37936957 | Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment |
| Q37717794 | Bacteria in cancer therapy: a novel experimental strategy |
| Q72074844 | Characterization of the diphtheria toxin receptor‐binding domain |
| Q34782295 | Clinical development of experimental therapies for malignant glioma. |
| Q30784536 | Clinical immunotherapy for brain tumors |
| Q38744447 | Convection-Enhanced Delivery |
| Q36478643 | Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas |
| Q27760510 | Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor |
| Q46628090 | Crystallization of diphtheria toxin |
| Q36891838 | Detection of differences in the nucleotide and amino acid sequences of diphtheria toxin from Corynebacterium diphtheriae and Corynebacterium ulcerans causing extrapharyngeal infections |
| Q33659905 | Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons |
| Q38108516 | Diphtheria toxin-based targeted toxin therapy for brain tumors |
| Q34060938 | Effect of therapeutic macromolecules in spheroids |
| Q36725665 | Endosome fusion induced by diphtheria toxin translocation domain |
| Q34127138 | Experimental approaches for the treatment of malignant gliomas |
| Q35118933 | Gene therapy and targeted toxins for glioma |
| Q57006162 | Gene therapy and targeted toxins for glioma |
| Q28631171 | Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity |
| Q72276322 | High-yield production of diphtheria toxin mutants by high-density culture of C7 (beta)tox+ strains grown in a non-deferrated medium |
| Q35967713 | Identification of a single amino acid substitution in the diphtheria toxin A chain of CRM 228 responsible for the loss of enzymatic activity |
| Q40380727 | Immunoconjugates and immunotoxins for therapy of carcinomas. |
| Q35210454 | Immunotoxin therapy for CNS tumor |
| Q34181903 | Immunotoxins |
| Q35459059 | Immunotoxins and anticancer drug conjugate assemblies: the role of the linkage between components |
| Q36725728 | Immunotoxins and central nervous system neoplasia |
| Q34646650 | Immunotoxins for targeted cancer therapy |
| Q79199423 | Immunotoxins for targeted cancer therapy |
| Q40931187 | Immunotoxins for treatment of leukemia and lymphoma |
| Q33745138 | Immunotoxins in cancer therapy |
| Q37220819 | Immunotoxins in the Therapy of Leukemias and Lymphomas |
| Q41119145 | In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme |
| Q36910686 | In vivo T-cell ablation by a holo-immunotoxin directed at human CD3 |
| Q73824761 | Intracellular targeting with low pH-triggered bispecific antibodies |
| Q34751465 | Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer |
| Q77466560 | Molecular basis of vaccination |
| Q36582396 | Molecular therapies for malignant glioma |
| Q41443177 | Mutagenesis of two surface-exposed loops of the Bacillus thuringiensis CryIC delta-endotoxin affects insecticidal specificity |
| Q36272990 | New delivery approaches for pediatric brain tumors |
| Q41094039 | On the membrane translocation of diphtheria toxin: at low pH the toxin induces ion channels on cells. |
| Q36968818 | Protein Engineering of DAB-IL-2 Fusion Toxins to Increase Biologic Potency |
| Q52220003 | Quantitative analysis of protein synthesis inhibition and recovery in CRM107 immunotoxin-treated HeLa cells. |
| Q40833031 | Rationale for the clinical use of immunotoxins: monoclonal antibodies conjugated to ribosome-inactivating proteins |
| Q36811133 | Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. |
| Q36425152 | Receptor-mediated uptake of an extracellular Bcl-x(L) fusion protein inhibits apoptosis |
| Q41022992 | Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges. |
| Q42939121 | Recombinant Immunotoxin Therapy of Solid Tumors: Challenges and Strategies |
| Q36533609 | Recombinant Toxins for Cancer Treatment |
| Q37165245 | Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies |
| Q34295821 | Recombinant immunotoxins in targeted cancer cell therapy |
| Q24675434 | Refined structure of monomeric diphtheria toxin at 2.3 A resolution |
| Q41332674 | Selective killing of T cells by immunotoxins directed at distinct V beta epitopes of the T cell receptor |
| Q37537586 | Serum proteins as drug carriers of anticancer agents: a review |
| Q42811918 | Subcloning and characterization of the binding domain of fragment B of diphtheria toxin |
| Q36737028 | Suppression of protein synthesis in brain during hibernation involves inhibition of protein initiation and elongation |
| Q33647683 | Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin. |
| Q35930279 | Targeted molecular therapy for malignant gliomas |
| Q35999648 | Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation. |
| Q37954275 | Targeted toxins in brain tumor therapy |
| Q99591448 | Targeting Receptors on Cancer Cells with Protein Toxins |
| Q28250331 | The crystal structure of diphtheria toxin |
| Q38686601 | The future of antiviral immunotoxins |
| Q27006226 | Toxin-based targeted therapy for malignant brain tumors |
| Q27013664 | Toxin-based therapeutic approaches |
| Q30885145 | Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas |
| Q48587395 | Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors |
Search more.